Timolol Maleate Ophthalmic Gel Forming Solution, 0.25% Solution/ Drops
NDC Package 46708-545-05
Package Information
Timolol Maleate Ophthalmic Gel Forming Solution, 0.25% solution/ dropses is a medication used to treat high pressure inside the eye due to glaucoma (open angle-type) or other eye diseases (e.g., ocular hypertension). This formulation utilizes a solution/ drops delivery system. Marketed by Alembic Pharmaceuticals Limited, this product is identified by NDC 46708-545 and is authorized under FDA application ANDA212942.
Identification & Billing
- RxCUI: 313407 - timolol maleate 0.25 % Ophthalmic Gel Forming Solution
- RxCUI: 313407 - timolol 0.0025 MG/MG Ophthalmic Gel
- RxCUI: 313407 - timolol 0.25 % Ophthalmic Gel
- RxCUI: 313407 - timolol 0.25 % Ophthalmic Gel Forming Solution
- RxCUI: 313408 - timolol maleate 0.5 % Ophthalmic Gel Forming Solution
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 46708 - Alembic Pharmaceuticals Limited
- 46708-545 - Timolol Maleate Ophthalmic Gel Forming Solution, 0.25%
- 46708-545-05 - 1 BOTTLE in 1 CARTON / 5 mL in 1 BOTTLE
- 46708-545 - Timolol Maleate Ophthalmic Gel Forming Solution, 0.25%
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 46708-545-05 identifies a specific commercial package of 1 bottle in 1 carton / 5 ml in 1 bottle of Timolol Maleate Ophthalmic Gel Forming Solution, 0.25%, a human prescription drug labeled by Alembic Pharmaceuticals Limited. This solution/ drops is formulated for ophthalmic use and contains timolol maleate as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Alembic Pharmaceuticals Limited on November 22, 2020. The current certification is valid through December 31, 2026.
What are the primary indications for this medication?
This medication is used to treat high pressure inside the eye due to glaucoma (open angle-type) or other eye diseases (e.g., ocular hypertension). Lowering high pressure inside the eye helps to prevent blindness. This medication works by decreasing the amount of fluid within the eye. Timolol belongs to a class of drugs known as beta-blockers.
How is this Alembic Pharmaceuticals Limited product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 46708054505. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.